Checkpoint Therapeutics News

Sun Pharma Expands Global Oncology Portfolio with $355 Million Acquisition of Checkpoint Therapeutics

Sun Pharma, India's largest drugmaker, is set to acquire Checkpoint Therapeutics for $355 million, enhancing its oncology portfolio with FDA-approved UNLOXCYT for advanced skin can...

Sun Pharma Announces Major Acquisition: Over Rs 3000 Crore Deal for US Oncology Firm

Sun Pharma, India's leading drugmaker, is set to acquire Checkpoint Therapeutics for over Rs 3000 crore, including the FDA-approved UNLOXCYT for advanced skin cancer. This move enh...